drugset / Trial / NCT03333499

the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure

NCT03333499

Phase 1 Unknown 80 enrolled Dalian University
RandomizedFactorialQuadruple-blindTreatment

Summary

The investigators set out to evaluate the effects of the traditional Chinese medicinal mixture under the brand name YangXinShi (YXS) on the prognosis in patients with chronic heart failure when it is combined with the optimal combination drug treatment of heart failure.

Timeline

Start
2017-11-01
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Trimetazidine Small molecule 20 mg Oral
Subject Yangxinshi Traditional medicine (herbal / TCM) 1800 mg Oral

Indications